According to insiders at IAVI, the International AIDS Vaccine Initiative (IAVI), a U.S. Department of Defense contractor, is ...

The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

It’s been five years since the COVID-19 pandemic changed everything—from the way we work to the way we think about global health. But what if another pandemic strikes tomorrow? Will the world be any ...

Promega technology used in the development of vaccines for infectious viral diseases will support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations' (CEPI's ...

Rwanda’s tourism industry raked in $647 million (approx. Rwf923billion) revenue in 2024, representing a slight increase of 4.3 percent compared to 2023, according to an annual Rwanda Development Board ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

Dr. Ngashi Ngongo, the Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the official handover ceremony in Luanda.

WHO Chief Dr. Tedros warns that another pandemic is inevitable, urging global preparedness. He stresses the urgency of ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...